Cooper DL - Search Results

1

Molecular mechanisms regulating the hyaluronan binding activity of the adhesion protein CD44.

Chiu RK, Droll A, Cooper DL, Dougherty ST, Dirks JF, Dougherty GJ. Chiu RK, et al. Among authors: cooper dl. J Neurooncol. 1995 Dec;26(3):231-9. doi: 10.1007/BF01052626. J Neurooncol. 1995. PMID: 8750189

2

Ligand binding specificity of alternatively spliced CD44 isoforms. Recognition and binding of hyaluronan by CD44R1.

Dougherty GJ, Cooper DL, Memory JF, Chiu RK. Dougherty GJ, et al. Among authors: cooper dl. J Biol Chem. 1994 Mar 25;269(12):9074-8. J Biol Chem. 1994. PMID: 7510702 Free article.

3

Adhesive interactions between alternatively spliced CD44 isoforms.

Droll A, Dougherty ST, Chiu RK, Dirks JF, McBride WH, Cooper DL, Dougherty GJ. Droll A, et al. Among authors: cooper dl. J Biol Chem. 1995 May 12;270(19):11567-73. doi: 10.1074/jbc.270.19.11567. J Biol Chem. 1995. PMID: 7538117 Free article.

4

Alternatively spliced CD44 isoforms containing exon v10 promote cellular adhesion through the recognition of chondroitin sulfate-modified CD44.

Chiu RK, Droll A, Dougherty ST, Carpenito C, Cooper DL, Dougherty GJ. Chiu RK, et al. Among authors: cooper dl. Exp Cell Res. 1999 Apr 10;248(1):314-21. doi: 10.1006/excr.1999.4391. Exp Cell Res. 1999. PMID: 10094837

5

Molecular cloning of CD44R1 and CD44R2, two novel isoforms of the human CD44 lymphocyte "homing" receptor expressed by hemopoietic cells.

Dougherty GJ, Landorp PM, Cooper DL, Humphries RK. Dougherty GJ, et al. Among authors: cooper dl. J Exp Med. 1991 Jul 1;174(1):1-5. doi: 10.1084/jem.174.1.1. J Exp Med. 1991. PMID: 2056274 Free PMC article.

6

Gene therapeutic approach to primary and metastatic brain tumors: I. CD44 variant pre-RNA alternative splicing as a CEPT control element.

Asman DC, Dirks JF, Ge L, Resnick NM, Salvucci LA, Gau JT, Becich MJ, Cooper DL, Dougherty GJ. Asman DC, et al. Among authors: cooper dl. J Neurooncol. 1995 Dec;26(3):243-50. doi: 10.1007/BF01052627. J Neurooncol. 1995. PMID: 8750190

7

To metastasize or not? Selection of CD44 splice sites.

Cooper DL, Dougherty GJ. Cooper DL, et al. Nat Med. 1995 Jul;1(7):635-7. doi: 10.1038/nm0795-635. Nat Med. 1995. PMID: 7585142 No abstract available.

8

Alternative splicing of CD44 pre-mRNA in human colorectal tumors.

Finn L, Dougherty G, Finley G, Meisler A, Becich M, Cooper DL. Finn L, et al. Among authors: cooper dl. Biochem Biophys Res Commun. 1994 Apr 29;200(2):1015-22. doi: 10.1006/bbrc.1994.1551. Biochem Biophys Res Commun. 1994. PMID: 7513991

9

The complex CD44 transcriptional unit; alternative splicing of three internal exons generates the epithelial form of CD44.

Cooper DL, Dougherty G, Harn HJ, Jackson S, Baptist EW, Byers J, Datta A, Phillips G, Isola NR. Cooper DL, et al. Biochem Biophys Res Commun. 1992 Jan 31;182(2):569-78. doi: 10.1016/0006-291x(92)91770-q. Biochem Biophys Res Commun. 1992. PMID: 1734871

10

Prognostic significance of CD44 expression in adenocarcinoma of the lung.

Clarke MR, Landreneau RJ, Resnick NM, Crowley R, Dougherty GJ, Cooper DL, Yousem SA. Clarke MR, et al. Among authors: cooper dl. Clin Mol Pathol. 1995 Aug;48(4):M200-4. doi: 10.1136/mp.48.4.m200. Clin Mol Pathol. 1995. PMID: 16696007 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

371 results

Search Page